Japan's Health Ministry appears set to announce approval on Friday
- Currently the Pfizer vaccine is approved for use in Japan
AZ vaccine may be age-limited due to blood clot risk
ADVERTISEMENT - CONTINUE READING BELOW
Search investingLive
Directory
Japan is likely to approve AsraZeneca, Moderna COVID-19 vaccines
ADVERTISEMENT - CONTINUE READING BELOW
Most Popular
- FT: Trump is pushing for 15 – 20% minimum tariff on all EU goods. EURUSD moves lower.
- Bitcoin analysis over the weekend, 28 June 2026
- Two revealing macro quotes from the FedEx earnings call
- investingLive Americas FX news wrap 26 Jun: Greenback ends mixed, still higher for week
- Major stock indices close modestly lower with the Nasdaq leading the way.
- Rubio: Framework raises hopes for peace, but major obstacles remain
- Crude oil settles the day/week at $69.23
ADVERTISEMENT - CONTINUE READING BELOW
Best in 2026
Sponsored
ADVERTISEMENT - CONTINUE READING BELOW
ADVERTISEMENT - CONTINUE READING BELOW
Telegram Community
Gain Access
Micron's AI memory boom could double its stock! Wall Street sees Nvidia-like potential, but innovation's long-term threat looms.
TechCrunch
15s ago
Micron's market cap soared past Meta & Tesla! Investors eye Nvidia-like gains, but innovation risks loom.
YahooFinance
36m ago
Micron's AI boom price tag: stock could double, but innovation threat looms. High returns, but watch valuation.
Seeking Alpha
1h ago
Utz recalls 684K bags of Zapp's & Dirty chips, FDA's highest risk. Salmonella fears hit valuation.
ABC11 News
1h ago
SpaceX's $17B spectrum buy fuels Starlink mobile push. VZ faces new rival. Revenue plans emerge.
thestreet
2h ago
AI stocks cool, rotation to value stocks boosts market. Tech faces valuation checks, but no bubble yet.
Investor's Business Daily
2h ago
Dollar hits 13-month high as investors shrug off Trump worries. Set for weekly gain.
Washington Post
3h ago
Telegram Community
Gain Access
Best in 2026
Sponsored
Must Read
!"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|} !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}